您的位置: 首页 > 农业专利 > 详情页

Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
专利权人:
ADC THERAPEUTICS SA;MEDIMMUNE LIMITED
发明人:
Howard, Philip Wilson,Van Berkel, Patricius Hendrikus Cornelis
申请号:
NZ70749013
公开号:
NZ707490A
申请日:
2013.10.11
申请国别(地区):
NZ
年份:
2018
代理人:
摘要:
The present invention relates to pyrrolobenzodiazepines (PBDs) having a labile N10 protecting group in the form of a linker to an antibody, wherein the antibody is an antibody that binds to CD22, the antibody comprising a VH domain paired with a VL domain, the VH and VL domains having sequences of SEQ ID NO. 1 paired with SEQ ID NO. 2. The drug loading (p) of drugs (D) to antibody (Ab) is an integer from 1 to 8. The present invention is suitable for use in providing a PBD compound to a preferred site in a subject. The conjugate allows the release of an active PBD compound that does not retain any part of the linker.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充